Podcasts about Type 2 diabetes

Scientific Sense ® by Gill Eapen: Prof Mike Snyder leads the center for genomics at Stanford. He collects and analyzes deep data from wearables to transform helathcare through analysis and behavior modifications.Please subscribe to this channel:https://www.youtube.com/c/ScientificSense?sub_confirmation=1

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by Raquel Baron, founder of Type One Together, to discuss the challenges, triumphs, and everyday realities of raising a child with type 1 diabetes. Diagnosed herself at age five, Raquel combines her lived experience with years of supporting families through Type One Together, an organization that provides trusted resources, educational programs, and a nationwide network of trained babysitters for children with type 1 diabetes. Together, Dr. Edelman and Raquel explore the emotional side of diabetes that often goes beyond blood sugars. They discuss helping children navigate school, sports, friendships, burnout, and growing independence, while giving parents practical strategies to reduce fear, build confidence, and create a healthier relationship with diabetes. The conversation also covers diabetes technology, social media, Afrezza for children, community support, and why perfection should never be the goal.Whether you're the parent of a newly diagnosed child or have been managing type 1 diabetes for years, this episode offers practical advice, reassurance, and reminders that children with diabetes can live full, active lives.✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/KPS865. CME/AAPA credit will be available until June 25, 2027.Bridging Knowledge to Action: Translating Evidence Into Practice for Type 2 Diabetes Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/KPS865. CME/AAPA credit will be available until June 25, 2027.Bridging Knowledge to Action: Translating Evidence Into Practice for Type 2 Diabetes Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/KPS865. CME/AAPA credit will be available until June 25, 2027.Bridging Knowledge to Action: Translating Evidence Into Practice for Type 2 Diabetes Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/KPS865. CME/AAPA credit will be available until June 25, 2027.Bridging Knowledge to Action: Translating Evidence Into Practice for Type 2 Diabetes Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/KPS865. CME/AAPA credit will be available until June 25, 2027.Bridging Knowledge to Action: Translating Evidence Into Practice for Type 2 Diabetes Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/KPS865. CME/AAPA credit will be available until June 25, 2027.Bridging Knowledge to Action: Translating Evidence Into Practice for Type 2 Diabetes Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

In this episode, we explore GLP-1 receptor agonists and their role in managing type 2 diabetes. We'll discuss how they work, their clinical benefits, routes of administration, common adverse effects, drug interactions, and key counseling points—all explained in a clear and practical way for healthcare professionals, students, and anyone interested in diabetes care.References: American Diabetes Association (ADA) Standards of Care in Diabetes, NCBI StatPearls, and official prescribing information.

Attend a Live Q&A with Dr. Glandt. Reigster here.What if the way we treat type 2 diabetes is fundamentally backwards?Dr. Mariela Glandt is an endocrinologist and obesity medicine specialist who spent 15 years practicing conventional medicine before concluding, in her words, that how we treat diabetes “is actually upside down.” As co-founder of OwnaHealth, she focuses on addressing the insulin resistance underlying type 2 diabetes, not only the elevated blood sugar it eventually causes.In this episode, she walks through the science of that shift: why fasting insulin may reveal metabolic dysfunction before A1C becomes abnormal, why a laboratory “normal” range running up to 20 can be misleading, and why she believes repeatedly escalating insulin can contribute to weight gain, reduced insulin responsiveness, and worsening metabolic health.She also shares what she has learned bringing low-carbohydrate and ketogenic therapy to underserved communities in the South Bronx, where patients may be navigating severe diabetes alongside financial pressure, cultural food traditions, psychiatric illness, chronic stress, and conflicting medical advice. Her work shows that these therapies can succeed even in communities facing significant barriers to care.Dr. Glandt also breaks down what GLP-1 medications actually do, where they can help, and what they may leave unresolved—including the risks of muscle loss, inadequate protein intake, and relying on medication without addressing the patient's broader metabolic health.Questions Answered in This Episode:• What key mindset shifts do conventionally trained physicians need to make when transitioning to a more integrated approach to medicine?• How does reframing diabetes as insulin resistance change the way a doctor practices?• What are the earliest signs of metabolic dysfunction that many clinicians miss?• Can ketogenic metabolic therapy succeed in underserved communities?• What do GLP-1 medications actually solve, and what do they leave untouched?• Where can ketogenic therapy and GLP-1 medications work together?• What has Dr. Glandt observed in patients living with both metabolic and psychiatric illness?• Where does endocrinology most need to change course?Viewers will come away with a different lens on metabolic disease, one that looks beyond glucose and weight to the biological, social, and practical factors shaping a patient's health.More links:For Richer, for Poorer: Low-Carb Diets Work for All IncomesOwnaHealth: Reverse the course of chronic disease — for everyone.Special thanks to the sponsors of this episode:✅ Toups and Co – Get 15% off your first order with code METABOLIC here.✅ iRestore – Get a huge discount on the Elite and the Illumina bundle with the code LINK here.In every episode of The Metabolic Link, we'll uncover the very latest research on metabolic health and therapy. If you like this episode, please share it, subscribe, follow, and leave us a comment or review on whichever platform you use to tune in!You can find us on all your major podcast players here and full episodes are also up on our Metabolic Health Summit YouTube channel!Find us on social: InstagramFacebookYouTubeLinkedInPlease keep in mind: The Metabolic Link does not provide medical or health advice, but rather general information that does not serve as a substitute for a licensed healthcare professional. Never delay in seeking medical advice from an appropriately licensed medical provider for any health condition that you may have.

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by pediatric endocrinologist Dr. Anna Cymbaluk, along with Philip and his father Jim, to discuss the recent FDA approval of Afrezza inhaled insulin for children and adolescents living with type 1 diabetes. Dr. Cymbaluk served as an investigator on the INHALE-1 trial, while Philip participated in the study himself, providing a unique real-world perspective on what it is like to transition from injections to inhaled insulin, and Philip's dad, Jim provided the parent perspective as well as addressed parental concerns that might have arisen.The conversation focuses on the INHALE-1 study and the unmet challenges that continue to exist around mealtime insulin dosing in pediatric diabetes care. Dr. Cymbaluk reviews the trial design, glucose outcomes, safety data, patient satisfaction findings, and the practical realities of introducing inhaled insulin into everyday diabetes management. Philip and Jim share how Afrezza impacted school, sports, social situations, and the day-to-day burden of diabetes, particularly around pre-bolusing, corrections, and avoiding multiple injections throughout the day.Dr. Edelman and Dr. Cymbaluk also explore how Afrezza is dosed, how inhaled insulin differs from injected insulin, who may be a good candidate, and where it may fit alongside pumps and automated insulin delivery (AID) systems. For families looking for more flexibility, fewer mealtime barriers, and another option in the diabetes toolbox, this episode provides an honest look at the benefits, limitations, and real-world experience of inhaled insulin in children and teens.Key Topics• The FDA approval of Afrezza for children and adolescents living with type 1 diabetes• The design and results of the INHALE-1 pediatric clinical trial• Patient satisfaction and quality-of-life outcomes from the study• The challenges of pre-bolusing and mealtime insulin management in children and teens• How inhaled insulin compares to traditional mealtime injections• Dosing strategies, cartridge sizes, and insulin conversion considerations• Using Afrezza for corrections, meals, and post-meal dosing• The role of continuous glucose monitoring (CGM) when using inhaled insulin• Safety findings, lung-function monitoring, and cough management• Who may be a good candidate for Afrezza—and who may not be• Benefits for active children, athletes, and those participating in sports• Social situations, injection avoidance, and reducing the burden of diabetes management• Using Afrezza alongside insulin pumps and automated insulin delivery (AID) systems• The importance of having more treatment options to individualize diabetes careSupported by an unrestricted educational grant from MannKind CorporationSubscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram: / tcoydFacebook: / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

In this podcast, Jennifer Green, MD, and Jay H. Shubrook, DO, FAAFP, FACOFP, share strategies for integrating incretin-based therapies in type 2 diabetes (T2D) management in the primary care setting, including: Importance of moving beyond a glucose-centric approach to T2D care  Current evidence for incretin-based therapies in T2D Rationale for integrating these therapies into the primary care setting Shared decision-making strategies to discuss optimal T2D treatment options with patients Timing for endocrinology referral Presenters: Jennifer Green, MD Professor of Medicine Division of Endocrinology Duke Clinical Research Institute Duke University School of Medicine Durham, North Carolina Jay H. Shubrook, DO, FAAFP, FACOFP Professor, Diabetologist Department of Clinical Sciences and Community Medicine Touro University California, College of Osteopathic Medicine Vallejo, California Full program link: https://bit.ly/4uSKCqv Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/GUX865. CME/AAPA credit will be available until June 8, 2027.Betting on Basal Insulin: Case Studies in Improving the Odds for People With Type 2 Diabetes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/GUX865. CME/AAPA credit will be available until June 8, 2027.Betting on Basal Insulin: Case Studies in Improving the Odds for People With Type 2 Diabetes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/GUX865. CME/AAPA credit will be available until June 8, 2027.Betting on Basal Insulin: Case Studies in Improving the Odds for People With Type 2 Diabetes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/GUX865. CME/AAPA credit will be available until June 8, 2027.Betting on Basal Insulin: Case Studies in Improving the Odds for People With Type 2 Diabetes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/GUX865. CME/AAPA credit will be available until June 8, 2027.Betting on Basal Insulin: Case Studies in Improving the Odds for People With Type 2 Diabetes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/GUX865. CME/AAPA credit will be available until June 8, 2027.Betting on Basal Insulin: Case Studies in Improving the Odds for People With Type 2 Diabetes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

I find it shocking that, as easy as type 2 diabetes is to reverse,  backed up by even human clinical trials validating this concept, few doctors inform their diabetic patients of this. Oddly, now that GLP-1 agonist (disastrous) drugs are available, the reduction in blood sugar coupled with weight loss has brought the idea of type 2 diabetes remission to the forefront, since it now is profitable to reverse it. But you do NOT need any pharmaceutical to reverse type 2 diabetes in the majority. Support the showYouTube channel: https://www.youtube.com/@WilliamDavisMDBlog: WilliamDavisMD.comMembership website for two-way Zoom group meetings: InnerCircle.DrDavisInfiniteHealth.comBooks:Super Gut: The 4-Week Plan to Reprogram Your Microbiome, Restore Health, and Lose WeightWheat Belly: Lose the Wheat, Lose the Weight and Find Your Path Back to Health; revised & expanded ed

Professor Donal O'Shea, specialist in obesity, responds to the National Centre for Pharmacoeconomics comments that Mounjaro could be deemed cost effective.

Is type 2 diabetes an incurable, progressive disease, as many doctors claim? The research says no. There is a simple, food-based approach that has been quietly studied since the 1970s, and it has helped people get their A1C back to normal without Metformin, without insulin, and without giving up a social life. In this episode, Chris Reade, entrepreneur and author of Beating Diabetes, shares his own story: his A1C jumped from normal to 9.1 in a single year, his doctor handed him a prescription and told him diabetes was an incurable, progressive disease. He walked out of that office and decided to find another way. Four months later, his A1C was back in the normal range. No Metformin. No insulin. No extreme diet. Listen now and start taking control of your blood sugar today! For show notes, visit https://fivejourneys.com/podcasts/soluble-fiber-may-be-your-best-tool-to-reverse-type-2-diabetes/  Follow us on Instagram at https://www.instagram.com/feelfreakingamazing/  Related Episodes Reverse Pre-Diabetes with a Fasting-Mimicking Diet, with Dr. Joseph Antoun How to Stop Taking Metformin, Insulin, and Ozempic for Good, with Dr. Jeffrey Hockings Lose Weight By Improving Your Leptin Sensitivity, with Dr. Bindiya Gandhi Lower Your Risk for Cancer & Chronic Diseases, with Dr. Greg Eckel Reverse Chronic Diseases using Allulose, with Neil Gyte Overcome 14 Chronic Illnesses, with Ashok Gupta Lose Weight By Getting Healthy, with Ben Azadi Try Keto for Optimal Health, with Robert & Crystal Sikes Leverage Ketosis and Fasting to Reverse Disease, with Ben Azadi Unlocking Longevity: Transform Your Health with a Fasting Mimicking Diet, with Dr. Joseph Antoun Why 16 Hours Isn't Enough for True Fasting Benefits, with Dr. Chris Rhodes Why Eating While Fasting Could Give You Better Results, with Renee Fitton

The World Cup is here, and while we watch some of the world's greatest athletes competing on a global stage, it's fascinating to consider what effect this intense activity may have on the human body. With that in mind, we're re-releasing our conversation with Stanford biochemist Jonathan Long on the future of exercise. Jonathan studies the chemistry of what happens inside your body when you move, and his findings are pointing toward some genuinely surprising possibilities — including treatments for obesity, diabetes, and even, someday, an exercise pill. If the athleticism on the pitch has you feeling inspired, this one is well worth another listen. Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu. Episode Reference Links: Stanford Profile: Jonathan Long Connect With Us: Episode Transcripts >>> The Future of Everything Website Connect with Russ >>> Threads / Bluesky / Mastodon Connect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Chapters: (00:00:00) Introduction Russ Altman introduces guest Jonathan Long, a professor of pathology from Stanford University. (00:02:02) Effective Weight Loss Drugs The history and development of GLP-1 receptor agonists. (00:04:04) Understanding Metabolism and Exercise Why Long's lab starts with molecules to understand metabolism and physical activity. (00:05:10) Animal Models in Exercise Studies The use of animal models in exercise studies and the discovery of Lac-Phe. (00:06:47) Psychological Preparation for Exercise The psychological aspects of exercise and the involvement of endocannabinoids in exercise motivation. (00:09:00) Lac-Phe's Role and Mechanism The role of Lac-Phe and its production in the gut. (00:12:08) Differences in Exercise Response Differences in exercise response between trained athletes and untrained individuals. (00:12:57) Diabetes and Metabolic Diseases The relationship between diabetes, exercise, and metabolic diseases. (00:15:01) Lac-Phe as a Potential Therapeutic The potential of Lac-Phe as a weight loss drug, and parallels to GLP-1 drug development. (00:16:21) Importance of How Weight is Lost Whether the method of weight loss matters, and the importance of preserving lean muscle mass. (00:18:37) Exercise as Medicine The concept of exercise as medicine, and defining physical activity at the same resolution as modern medicines. (00:22:11) Metformin and Exercise Pathways The unexpected connection between metformin and the Lac-Phe pathway. (00:24:01) Prospects of an Exercise Pill The future of an exercise pill, and the challenges associated with its development. (00:27:05) Conclusion Final thoughts on the future of exercise. Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

If you've ever thought, “I know what to do, so why can't I do it,” this conversation hits the nerve and gives you a way out. We sit down with Dr. John Oberg, a human behavior strategist and healthcare innovator whose work targets one of the biggest problems in modern health: chronic metabolic disease and type 2 diabetes. Along the way, John shares a near-death car crash story that reshaped how he sees faith, relationships, and service, and why that personal turning point connects directly to how people change when the stakes are real.We get concrete about what actually moves the needle: how hemoglobin A1C works, why tiny sustainable swaps can drive major blood sugar improvement, and why most “go hard on Monday” plans collapse under stress. John breaks down his core framework: focus on what you control (your thoughts and your actions), build small habits you can repeat, and create the right support system so your environment stops fighting you. We also talk GLP-1 medications, insulin, and modern telemedicine, not as magic fixes, but as tools that can help patients stabilize, lower treatment burden, and eventually reduce dependence on medication with food-as-medicine strategies.You'll also hear practical guidance you can use today: “move right” by shifting from processed food toward whole food, “move more” with 10-minute blocks of intentional walking, and stop grazing all day so your body gets clear fed and fasting periods. We even share a blunt, compassionate patient story framed as Door A, Door B, or Door C that shows what non-judgmental care really looks like when someone feels stuck.If this helped you, subscribe, share it with a friend who needs hope, and leave a review so more people can find these conversations. What's one small change you're willing to start this week?Join the What if it Did Work movement on FacebookGet the Book!www.omarmedrano.comwww.calendly.com/omarmedrano/15min

In this episode of the TCOYD Podcast, Dr. Edelman and Dr. Pettus are joined by pediatric endocrinologist Dr. Jamie Wood, medical director of pediatric diabetes at Rainbow Babies & Children's Hospital and an investigator on the INHALE-1 trial, to talk through inhaled insulin in kids and where it fits in real-world pediatric care.The conversation focuses on the recent approval of Afrezza for children as young as six, and what the INHALE-1 trial actually showed. Dr. Wood walks through the study design, A1C results, lung-function and safety data, and the practical aspects of dosing inhaled insulin in a pediatric population. Rather than positioning it as a replacement for injections or pumps, the discussion centers on finding the right fit for each child's needs, from the newly diagnosed kid with a needle phobia to the teen trying to dose discreetly during a 20-minute school lunch.Dr. E, Dr. P, and Dr. Wood also discuss the everyday realities that shape how this option is used, including the set-dose cartridge sizes, a titration approach refined in clinic, and how families are mixing and matching tools alongside automated insulin delivery. The takeaway is encouraging: there are more options than ever for managing mealtime insulin in kids, and this one may help fill some of the gaps left by injections and pumps.Key Topics • The recent approval of inhaled insulin for children as young as six • How the INHALE-1 pediatric trial was designed • A1C results and what the primary endpoint analysis showed • Continuous glucose monitor (CGM) metrics across the two groups • Lung-function (FEV1) monitoring and pediatric safety • Weight and body mass index (BMI) findings • Why mealtime dosing is a leading unmet need in pediatric type 1 diabetes (T1D) • The set-dose cartridge approach and how it reframes meal sizes • A real-world titration method for inhaled insulin • Managing cough and other practical considerations • Needle phobia and the kids who struggle most with injections • Using inhaled insulin alongside automated insulin delivery (AID) systems • What's coming next, including a smaller cartridge dose and a new-onset trial Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram: / tcoydFacebook: / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

Perimenopause, Insulin Resistance, and Persistent Muscle & Joint Pain: A Functional Medicine Framework: Nutritionist Leyla Muedin discusses perimenopausal musculoskeletal symptoms—new or persistent joint pain, muscle aches, and tendon problems—and highlights a Clinician's Journal article by physical therapist Tara Moore proposing insulin resistance screening in perimenopausal musculoskeletal care. She explains that declining estradiol during the menopausal transition can worsen insulin signaling, increase visceral fat, and reduce insulin sensitivity, affecting skeletal muscle recovery and potentially contributing to tendinopathies and poor or short-lived responses to localized treatments like PT. The framework emphasizes assessing systemic metabolic contributors (e.g., sedentary behavior, high-carbohydrate nutrition patterns, PCOS, central weight gain, stress, sleep disruption) and addressing mediators such as inflammation and impaired glucose utilization. She suggests integrating metabolic risk assessment, sleep and stress strategies, resistance training, and interdisciplinary referrals, arguing that nutrition and supplementation—especially a low-carb approach—may improve recovery and pain outcomes.

Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. Lots going on in this new episode! Three new pieces of research and an interview with Dr Anna Martinez, consultant paediatric dermatologist at GOSH, talking about a skin fragility condition many of us may not have heard of before - epidermolysis bullosa - in conjunction with DEBRA, the leading charity for EB awareness and research. In research, we look at two papers published this week in finerenone. Does it have a role in CKD management in patients without diabetes, and if so, how good is it?Second, retatruide - the latest injectable weight loss medication making a splash across the headlines - could it be used as monotherapy for recent onset type 2 diabetes?ResourcesNB Medical Epidermolysis bullosa free online educational moduleDEBRANEJM Finerenone for CKDLancet Finerenone MALancet Retatrutide for early T2DMwww.nbmedical.com/podcast

Is there a diet that can help reverse type 2 diabetes? Discover how to reverse diabetes naturally with a diet that improves blood sugar control, eliminates cravings, and reduces insulin resistance.0:00 The diet that reverses diabetes naturally0:23 Can you reverse diabetes?1:38 Insulin resistance and prediabetes 5:09 High blood sugar explained 6:08 Side effects of type 2 diabetes 6:47 How to reverse diabetes naturally 8:49 A low-carb diet and intermittent fasting 9:30 Signs of blood sugar problems10:13 The best diabetes diet plan12:15 Foods to avoid if you have type 2 diabetes12:58 Natural blood sugar control

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3424: Jacquelyn Cafasso shares practical snack ideas that make it easier to manage type 2 diabetes without spending time on complicated meal prep. From protein-rich nuts and Greek yogurt to fiber-packed vegetables, avocados, and popcorn, these simple options can help support steady blood sugar levels while keeping hunger under control throughout a busy day. Read along with the original article(s) here: https://www.healthline.com/health/type-2-diabetes/grab-and-go-snacks Quotes to ponder: "Studies show that having at least five servings per week of nuts is significantly associated with a lower risk of cardiovascular disease." "Air-popped popcorn is a great snack option for people with type 2 diabetes." "When you have type 2 diabetes, you can snack smart by aiming for items high in protein and fiber, but low in sodium and sugar." Episode references: U.S. Department of Agriculture (USDA): https://www.usda.gov American Diabetes Association: https://diabetes.org Learn more about your ad choices. Visit megaphone.fm/adchoices

The “Enhanced Games”, with no-holds-barred performance-enhancing drugs, yields scant advantages over “clean” contests; Does saturated fat increase insulin resistance? Can a heart attack victim avoid statin use with CoQ10? Omega-3 fish oil shows promise vs. type 2 diabetes; Motorized e-scooter use needs to be regulated NOW!

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3424: Jacquelyn Cafasso shares practical snack ideas that make it easier to manage type 2 diabetes without spending time on complicated meal prep. From protein-rich nuts and Greek yogurt to fiber-packed vegetables, avocados, and popcorn, these simple options can help support steady blood sugar levels while keeping hunger under control throughout a busy day. Read along with the original article(s) here: https://www.healthline.com/health/type-2-diabetes/grab-and-go-snacks Quotes to ponder: "Studies show that having at least five servings per week of nuts is significantly associated with a lower risk of cardiovascular disease." "Air-popped popcorn is a great snack option for people with type 2 diabetes." "When you have type 2 diabetes, you can snack smart by aiming for items high in protein and fiber, but low in sodium and sugar." Episode references: U.S. Department of Agriculture (USDA): https://www.usda.gov American Diabetes Association: https://diabetes.org Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us Fan MailEvery year, one in five adults with Type 1 diabetes experiences a dangerous drop in blood sugar that renders them unable to treat themselves. These severe hypoglycemic events are still happening, even though many patients now use continuous glucose monitors and automated insulin pumps.Why has this trade-off between long-term A1C control and dangerous sugar crashes persisted for over 30 years?Bob Geho, Founder and CEO of Diasome, joins host David E. Williams to unpack the results of the company's 200+ patient Phase 2B OPTI-2 trial of HDV™ insulin. The study was presented recently at the American Diabetes Association meeting in New Orleans.In the trial, five patients using standard insulin experienced severe hypoglycemic events. This compares with zero such events among patients receiving HDV™ insulin. Meanwhile, HDV™ insulin matched standard-of-care A1C control.Bob also shares how the HDV platform is being studied for its potential to reduce side effects in GLP-1 therapy and to address insulin resistance, considered the root cause of Type 2 Diabetes.

Learn how fat buildup in muscle cells disrupts insulin and how a low-fat plant-based diet restores metabolic function. #Type2Diabetes #InsulinResistance #LowFatVegan

In this special live episode of The Life Possible Podcast, recorded at the 2026 Ideal Protein Calgary Super Weekend, Dr. John Barnes sits down with Dr. Jonathan Little, professor and researcher at the University of British Columbia, to discuss groundbreaking clinical research exploring the Ideal Protein Protocol use in Type 2 diabetic patients.Dr. Little shares the results of a landmark study involving 188 participants living with Type 2 diabetes. The findings included significant weight loss, improved blood sugar control, substantial reductions in diabetes medications, and remission in some participants. These results were influential enough to help inform Diabetes Canada's clinical practice guidelines, making it the first diabetes organization in the world to formally recognize Type 2 diabetes remission.The conversation also includes an exclusive preview of Dr. Little's ongoing DECIDE Trial, which compares the Ideal Protein Protocol head-to-head against a standard whole-food ketogenic diet to determine which approach is most effective for achieving similar results in Type 2 diabetic patients.Whether you're living with Type 2 diabetes, struggling with insulin resistance, caring for patients, or simply interested in the science of metabolic health, this episode offers an exciting look at the growing evidence that nutrition can be a powerful tool for improving metabolic health.

In this episode, we break down the science behind GLP-1 medications including Ozempic, Wegovy, Zepbound, Mounjaro, semaglutide, and tirzepatide. Learn how GLP-1 weight loss medications work, their role in appetite suppression, insulin regulation, metabolic health, obesity treatment, and type 2 diabetes management.This evidence-based discussion explores GLP-1 benefits, side effects, muscle loss concerns, weight regain after stopping medication, nutrition considerations, digestion, metabolic adaptation, and sustainable wellness strategies. If you're considering GLP-1 medications or simply want a smarter conversation about obesity medicine, weight loss, longevity, and metabolic health, this episode delivers a clinically grounded wellness perspective. Disclaimer: This podcast is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. The views shared are intended to support informed wellness conversations and should not replace individualized guidance from your physician or qualified healthcare provider. Always consult your healthcare team before making decisions regarding medications, treatment, nutrition, or health management.

DR. JASON SHUMARD is a Functional Medicine practitioner with more than two decades helping people with Type 2 Diabetes and insulin resistance find true answers, especially those who feel confused by conventional approaches. Rather than seeing diabetes as just about numbers, he focuses on lab-based, root-cause investigation into why blood sugar rises and disease progresses, going far deeper than "eat less sugar" or "more meds." Dr. Shumard makes metabolic and cellular health understandable for everyone, empowering individuals to take the reins on their own health journeys. His passion is deeply personal, stemming from losing his mother to diabetes complications, which drives his mission to transform patient experience from one of fear to informed action  www.drshumard.com  

What diabetes technology is actually helping people right now—and how do you figure out what fits best into your life?In this 100th episode of the TCOYD Podcast, Dr. E and Dr. P are joined by diabetes nurse practitioner and educator Rachael Sood, founder of The Diabetes Collective, to talk through the latest updates in diabetes technology and what they're seeing in real-world diabetes care.The conversation focuses on how much diabetes technology has changed over the past few years, from hybrid closed loop systems and CGMs to new developments in sensing and automation. Rather than focusing on one “best” device, the discussion centers around finding the right fit for each person's lifestyle, preferences, and goals.Dr. E, Dr. P, and Rachael also talk about where technology may be headed next, including dual glucose and ketone sensors, more compatibility between pumps and CGMs, and the possibility of systems that require less hands-on work from people living with diabetes. The takeaway is encouraging: there are more tools and options than ever before, and diabetes technology continues to move toward making daily management simpler, safer, and more flexible.Key Topics• Choosing the right insulin pump and CGM• Tubed vs. tubeless pump systems• How lifestyle and personal preference shape technology choices• The latest updates in automated insulin delivery systems• Dexcom G7 10-day vs. 15-day sensors• Abbott's dual glucose and ketone sensor technology• Medtronic's newest technology developments• Real-world conversations patients have about wearing devices• Continuous ketone monitoring and DKA prevention• The future of fully closed loop systems• Why compatibility between pumps and CGMs matters• Technology options for people with type 2 diabetes• Where diabetes technology may be headed next✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/PEV865. CME/AAPA credit will be available until May 22, 2027.Betting on Basal Insulin: Improving the Odds for People With Type 2 Diabetes (Updates From Las Vegas) In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/PEV865. CME/AAPA credit will be available until May 22, 2027.Betting on Basal Insulin: Improving the Odds for People With Type 2 Diabetes (Updates From Las Vegas) In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/PEV865. CME/AAPA credit will be available until May 22, 2027.Betting on Basal Insulin: Improving the Odds for People With Type 2 Diabetes (Updates From Las Vegas) In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

Asians are at a significantly higher risk of developing type 2 diabetes than the general population. Dr. Jonar De Guzman specializes in coaching Asians to reverse insulin resistance with lifestyle changes. I learned a lot and had a great time chatting about working on living a healthier lifestyle!  I know you will learn something if you listen to this episode! Learn more @reversediabetesdoc on social media, or Dr. Jonar's coaching website https://4truthhealthcoaching.com/. Check out his podcast Glass Half Healthy wherever you listen to podcasts! Check out our website for podcast updates as well as all our older episodes at www.infatuasian.com  or write to us at infatuasianpodcast@gmail.com Our Theme: “Super Happy J-Pop Fun-Time” by Prismic Studios was arranged and performed by All Arms Around  Cover Art and Logo designed by Justin Chuan @w.a.h.w (We Are Half the World) #asianpodcast #asianamerican #infatuasian #representationmatters

Sami Inkinen (@samiinkinen) is a Finnish-born, Stanford-trained entrepreneur and the founder and CEO/president of Trulia and Virta Health. Virta is on a mission to reverse metabolic disease in one billion people using technology, AI, and nutrition. A world-class endurance athlete, Sami is a triathlon age-group world champion and an 8-hour, 24-minute Ironman finisher, having completed the Hawaii Ironman World Championship seven times.This episode is brought to you by:Eight Sleep Pod Cover 5 sleeping solution for dynamic cooling and heating: EightSleep.com/TimAG1 all-in-one nutritional supplement: DrinkAG1.com/TimWealthfront high-yield cash account: Wealthfront.com/Tim Wealthfront disclaimer: New clients get 3.30% base APY from program banks + additional 0.75% boost for 3 months on your uninvested cash (max $150k balance). Terms and conditions apply. The Cash Account offered by Wealthfront Brokerage LLC (“WFB”) member FINRA/SIPC, not a bank. The base APY as of 1/30/26 is representative, can change, and requires no minimum. Tim Ferriss, a non-client, receives compensation from WFB for advertising and holds a non-controlling equity interest in the corporate parent of WFB, which creates a conflict of interest. Individual experiences and outcomes will differ. Instant withdrawals may be limited by your receiving firm and other factors. Investment advisory services provided by Wealthfront Advisers LLC, an SEC-registered investment adviser. Securities investments: not bank deposits, not bank-guaranteed or FDIC-insured, and may lose value.DISCLAIMER:The content of this episode is for informational purposes only. Neither Sami Inkinen nor Tim Ferriss is a medical professional, and nothing discussed here should be taken as medical advice or a substitute for consultation with a qualified healthcare provider.Timestamps:[00:00] Start.[01:45] How Sami uses 15 minutes every Sunday to outrun the universe.[03:37] Virta: at a thousand employees and counting.[04:15] The 5 a.m. boot-up: cold lake, core work, and emptying the dishwasher.[06:45] Why mood follows movement before the brain even boots up.[11:54] Saying no to 99% of what “normal people” do.[19:29] The weekly architecture.[20:29] Two direct reports: the case for radical subtraction.[21:09] 553 CEO letters and the case for one scalable habit.[32:36] The text-file life plan.[33:32] The 15-year personal plan Sami stumbled into by accident.[34:30] The four-pillar formula for not cracking in 26 years of founder life.[38:20] What “white Japanese people” and beer steins in saunas have in common.[45:55] Smoke saunas, löyly, and the one Finnish word worth knowing.[48:37] The lean, ten-percent-body-fat triathlete who was quietly going prediabetic.[53:07] Why 93% of American adults are metabolically unhealthy.[56:05] Reversing type 2 diabetes the way Virta actually does it.[1:00:17] Most surprising interventions.[1:03:32] The pancreatic cancer trial that bought patients 35% more time.[1:07:02] The McDonald's protocol: how to reverse diabetes from the drive-thru.[1:16:00] Why GLP-1 adherence collapses and Virta's doesn't.[1:21:10] Vegans, tofu, and the hardest macronutrient to get right.[1:25:27] The dose-response curve that lets perfect stop being the enemy of progress.[1:29:32] VO2 max blocks: how Sami trains an 80+ engine without burning out.[1:41:56] Hacking 10% off your running speed in four weeks.[1:46:09] Progressive overload, specificity, and the case against the long ride.[1:50:07] 45 days, three hours, and a contract to keep a marriage afloat.[1:55:27] The lightning strike in the middle of the Pacific that started a family.[2:01:15] The 36-year-old who bought his first car only because his wife made him.[2:05:40] The book recommendation no one saw coming: Trejo.[2:07:51] The PSA: chronic, progressive, and irreversible — three words Sami refuses.[2:11:40] Parting thoughts.*For show notes and past guests on The Tim Ferriss Show, please visit tim.blog/podcast.For deals from sponsors of The Tim Ferriss Show, please visit tim.blog/podcast-sponsorsSign up for Tim's email newsletter (5-Bullet Friday) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim's books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissYouTube: youtube.com/timferrissFacebook: facebook.com/timferriss LinkedIn: linkedin.com/in/timferrissSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us Fan MailDr. Jason Shumard, D.C. has postgraduate education in functional endocrinology and clinical nutrition. Over the last twenty years, he has worked with patients with a multitude of conditions, specifically however focusing on helping people reverse their type II diabetes. Dr. Shumard is passionate about helping patients overcome their diabetes and take control over their health.Dr. Shumard is the owner of DrShumard.com, which he opened in 2005 with the desire to promote safe alternative reversal strategies and protocols to those suffering with Type 2 diabetes across the United States.Dr. Shumard received a B.S. degree in Kinesiology from San Diego State University in 2000 and furthered his education with a Doctorate of Chiropractic from Life Chiropractic College West in 2004. Dr. Shumard is also a sought-after practitioner and speaker working with type II diabetics and is often found volunteering in numerous charity and community events. DrShumard.com is founded on the principles of true healing, and the Dr. Shumard's intention is to not only help his patients with exceptional corrective care, but also to educate them on healthy and functional lifestyles that will support the patient's health and well-being for the rest of their lives.Find Dr. Jason Shumard at-https://drshumard.com/IG- @drjasonshumardFind Boundless Body at-myboundlessbody.comBook a session with us here! 

What if something was going on with your health and you didn't feel any symptoms at all? Could it be metabolic dysfunction-associated steatohepatitis (MASH)? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus talk about fatty liver and MASH, a condition that can develop quietly but still has a real impact over time. They're joined by patient advocate Manuel Oliver, who shares his experience after being diagnosed and what helped him turn things around. They explain why fatty liver is so common, especially in people with metabolic conditions, and why it often goes unnoticed. The conversation also highlights how things can change over time, even when you feel okay, and why routine checkups matter.Manuel shares what it was like to hear his diagnosis, how it affected him, and the steps he took to improve his health. You'll also hear how care has evolved, including better ways to detect liver disease and more options to support treatment alongside lifestyle changes.The message is simple: this condition can be serious, but there are ways to manage it, and taking action can make a meaningful difference.✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

Registered dietitian nutritionist Leyla Muedin discusses a Nature Communications study of 108,723 French adults in the NutriNet-Santé cohort (2009–2023) examining long-term exposure to food preservatives and type 2 diabetes. Using detailed dietary records cross-referenced with product/additive databases, researchers identified 58 preservative-related additives and analyzed 17 consumed by at least 10% of participants; 1,131 diabetes cases occurred. Higher overall preservative intake was associated with a 47% increased diabetes risk (49% for non-antioxidant preservatives; 40% for antioxidant additives), with several specific additives linked to higher risk. Leyla questions whether the findings reflect preservatives themselves or the ultra-processed, refined-carbohydrate foods that contain them, emphasizing recommendations to favor fresh, minimally processed foods and limit refined carbs and processed foods.

Gary Taubes on Rethinking Diabetes: Diet, Insulin, and the History Behind Low-Carb Treatment: Journalist Gary Taubes is author of “Rethinking Diabetes: What Science Reveals About Diet, Insulin, and Successful Treatments.” The book traces diabetes treatment history and argues that carbohydrate restriction was standard care from 1797 through the early 20th century until insulin therapy shifted practice toward drug-centered management and higher-carbohydrate diets. Taubes explains how insulin's discovery changed dietary priorities, how later technology (radioimmunoassay) revealed that most diabetes is type 2 with insulin resistance and high insulin rather than deficiency, and why giving more insulin can worsen weight gain. They discuss major trials (including ACCORD, ADVANCE, and Look AHEAD) that failed to show benefits from intensive drug-based glucose control, the influence of low-fat guidelines, Richard Bernstein's role in blood-glucose self-monitoring and low-carb control, controversies about obesity models, ketosis vs ketoacidosis, GLP-1 drugs, and LDL increases on ketogenic diets.

What happens when a pharmacist of 30+ years realizes the system she was trained in isn't actually helping people heal? In this powerful conversation, I sit down with Amanda Yue, PharmD, to discuss her journey from conventional pharmacy to root-cause healing—and the life-changing results that followed. Amanda shares how her 80-year-old mother-in-law, who was facing foot amputation due to long-standing type 2 diabetes, was able to not only avoid surgery—but reverse her diabetes and regain her memory after early signs of cognitive decline. We also dive into Amanda's personal health struggles, including 27 years of psoriasis, leaky gut, hormonal imbalances, and chronic symptoms despite "normal" lab work—and what finally helped her heal. A major part of this transformation came from implementing the Feel Great System, which includes a concentrated yerba mate tea and a fiber matrix supplement. These tools helped address insulin resistance, reduce food cravings, and stabilize blood sugar—unlocking the body's ability to heal. This conversation goes beyond one success story. Amanda explains how the same approach helped improve her entire family's health, from blood sugar and weight to focus and hormonal balance. If you've ever felt stuck, frustrated, or like nothing is working—this episode will challenge what you've been told and show you what's actually possible when you address the root cause. Amanda's experience as a pharmacist and why patients keep getting worse Her personal struggles with leaky gut, psoriasis, and hormonal imbalance Why "normal labs" don't always mean you're healthy How her 80-year-old mother-in-law avoided amputation Reversing type 2 diabetes naturally The role of the Feel Great System (concentrated yerba mate + fiber matrix) The connection between insulin resistance and memory loss Improvements in cognitive function and early dementia symptoms Why medications like statins and PPIs may not address the real issue The role of insulin resistance in weight gain, inflammation, and chronic disease How this approach impacted her entire family (PCOS, Hashimoto's, ADD, and more)

Worried about prediabetes or your risk for Type 2 diabetes? In this episode of Dishing Up Nutrition, learn how insulin resistance develops and why it often goes unnoticed for years. Discover how real food, balanced meals, and simple lifestyle habits can help stabilize blood sugar and prevent or even reverse Type 2 diabetes, and walk away with practical, realistic strategies to support long-term metabolic health and feel more in control of your future.

Registered dietitian nutritionist Leyla Muedin discusses how exposure to natural daylight may improve metabolic health beyond diet and exercise, highlighting a controlled crossover study of 13 adults aged 65+ with type 2 diabetes published in Cell Metabolism. Participants spent 4.5 days in living spaces lit by either natural light through large windows or artificial light, with identical meals, sleep, activity, and screen time; after a 4-week washout they switched conditions. Natural light was associated with more hours of blood glucose in the normal range, less glucose variability, higher evening melatonin, and improved fat oxidative metabolism, suggesting effects on circadian “body clocks” and coordination between central and peripheral clocks. Muedin recommends getting morning light on the face, reducing sunglasses and high SPF use, dimming lights at night, keeping consistent sleep, and spending more time outdoors; she also notes that architecture can limit sunlight exposure.